Curi Wealth Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-51	Closed	–	–	470
2022 Q2	$0	Buy	+51	New	–	﹤0.01%	683